Skip to main content
. Author manuscript; available in PMC: 2021 Jul 14.
Published in final edited form as: Vaccine. 2020 Jun 19;38(33):5119–5122. doi: 10.1016/j.vaccine.2020.05.056

Table 2.

Unadjusted Odds Ratios (UOR) and 95% Confidence Intervals (CI) of HPV Receipt and Adherence (Reference = “1–2 HPV Doses) Young Adults (Age 18–29 years) from Nine States Behavioral Risk Factor Surveillance System, 2015

ALL HPV Doses NO HPV Dose
UOR 95% CI Sig UOR 95% CI Sig
Sex
 Female 4.85 [2.47, 9.53] *** 0.41 [0.26, 0.67] ***
 Male (Ref)
Race/Ethnicity
 Non-Hispanic White (Ref)
 African American 0.39 [0.16, 0.97] * 0.79 [0.44, 1.42]
 Hispanic 0.47 [0.23, 0.99] * 0.73 [0.41, 1.29]
 Other Race 0.42 [0.14, 1.24] 0.49 [0.17, 1.42]
Age Group
 18–24 Years (Ref)
 25–29 Years 1.30 [0.73, 2.30] 3.47 [2.11, 5.70] ***
Influenza Immunizations
 Yes, past year 0.92 [0.52, 1.61] 0.53 [0.32, 0.87] *
 No (Ref)
Region
 Northeast
 Midwest 0.72 [0.45, 1.14] 1.32 [0.90, 1.93]
 South 0.55 [0.38, 0.80] ** 1.27 [0.95, 1.71]
 West 0.80 [0.49, 1.31] 1.41 [0.94, 2.10]

Note: Based on 3,880 young adults in the age group 18–29 years from nine states and who did not have missing values in human papillomavirus vaccination variable. Significant group differences were tested with Rao-Scott chi-squares. UORs and 95% Cis are from unadjusted multinomial logistic regression on HPV receipt and adherence.

HPV: Human Papillomavirus Vaccination